Juan García Burgos of the EMA tells Faraz Kermani about the expanding role of the patient in agency decisions.
The European Medicines Agency has been interacting with patients, healthcare professionals, academia, the pharmaceutical industry and other interested parties since it was first set up in 1995...
Please login to read the full article.
